Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice

Acta Physiologica

Volumn 217, Issue 4, 2016, Pages 300-310

  Ahl, D ^a   Liu, H ^a   Schreiber, O ^a   Roos, S ^b   Phillipson, M ^a   Holm, L ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

colon; dextran sulphate sodium; inflammatory bowel disease; mucus thickness; probiotics; tight junctions

Indexed keywords

DEXTRAN SULFATE; DRINKING WATER; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; OCCLUDIN; PROTEIN ZO1; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CLINICAL EVALUATION; CLINICAL OBSERVATION; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; KERATINOCYTE; LACTOBACILLUS REUTERI; MALE; MICROPIPETTE; MOUSE; MUCUS; MUCUS THICKNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84979009891     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12695     Document Type: Article

References (38)

1. Al-Sadi, R., Ye, D., Dokladny, K. & Ma, T.Y. 2008. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 180, 5653–5661.
2. Angulo, S., Llopis, M., Antolin, M., Gironella, M., Sans, M., Malagelada, J.R., Pique, J.M., Guarner, F. & Panes, J. 2006. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol 291, G1155–G1162.
3. Atuma, C., Strugala, V., Allen, A. & Holm, L. 2001. The adherent gastrointestinal mucus gel layer: thickness and physical state invivo. Am J Physiol Gastrointest Liver Physiol 280, G922–G929.
4. Bibiloni, R., Fedorak, R.N., Tannock, G.W., Madsen, K.L., Gionchetti, P., Campieri, M., De Simone, C. & Sartor, R.B. 2005. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100, 1539–1546.
5. Cobo, E.R., Kissoon-Singh, V., Moreau, F. & Chadee, K. 2015. Colonic MUC2 mucin regulates the expression and antimicrobial activity of beta-defensin 2. Mucosal Immunol 8, 1360–1372.
6. Cooper, H.S., Murthy, S.N., Shah, R.S. & Sedergran, D.J. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238–249.
7. Da Silva, S., Robbe-Masselot, C., Ait-Belgnaoui, A., Mancuso, A., Mercade-Loubiere, M., Salvador-Cartier, C., Gillet, M., Ferrier, L., Loubiere, P., Dague, E., Theodorou, V. & Mercier-Bonin, M. 2014. Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am J Physiol Gastrointest Liver Physiol 307, G420–G429.
8. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W. & Boirivant, M. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174, 3237–3246.
9. Dicksved, J., Schreiber, O., Willing, B., Petersson, J., Rang, S., Phillipson, M., Holm, L. & Roos, S. 2012. Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS One, 7, e46399.
10. FAO 2001. Report of a Joint FAO/WHO Expert Consultation on Evalution of Health and Nutritional Properties of Propiotics in Food including Powder Milk with Live Lactic Acid Bacteria. FAO Food and Nutrition Paper.
11. Gupta, P., Andrew, H., Kirschner, B.S. & Guandalini, S. 2000. Is lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31, 453–457.
12. Hollander, D., Vadheim, C.M., Brettholz, E., Petersen, G.M., Delahunty, T. & Rotter, J.I. 1986. Increased intestinal permeability in patients with Crohn’s disease and their relatives. A possible etiologic factor. Ann Intern Med 105, 883–885.
13. Johansson, M.E.V., Phillipson, M., Petersson, J., Velcich, A., Holm, L. & Hansson, G.C. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105, 15064–15069.
14. Johansson, M.E.V., Gustafsson, J.K., Sjöberg, K.E., Petersson, J., Holm, L., Sjövall, H. & Hansson, G.C. 2010. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One, 5, e12238.
15. Johansson, M.E., Gustafsson, J.K., Holmen-Larsson, J., Jabbar, K.S., Xia, L., Xu, H., Ghishan, F.K., Carvalho, F.A., Gewirtz, A.T., Sjovall, H. & Hansson, G.C. 2014. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281–291.
16. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A. etal. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124.
17. Mack, D.R., Michail, S., Wei, S., McDougall, L. & Hollingsworth, M.A. 1999. Probiotics inhibit enteropathogenic E.coli adherence invitro by inducing intestinal mucin gene expression. Am J Physiol 276, G941–G950.
18. Madsen, K.L., Doyle, J.S., Jewell, L.D., Tavernini, M.M. & Fedorak, R.N. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107–1114.
19. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L. & De Simone, C. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591.
20. Mao, Y., Nobaek, S., Kasravi, B., Adawi, D., Stenram, U., Molin, G. & Jeppsson, B. 1996. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111, 334–344.
21. Mattar, A.F., Teitelbaum, D.H., Drongowski, R.A., Yongyi, F., Harmon, C.M. & Coran, A.G. 2002. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 18, 586–590.
22. Mennigen, R., Nolte, K., Rijcken, E., Utech, M., Loeffler, B., Senninger, N. & Bruewer, M. 2009. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296, G1140–G1149.
23. Meyer-Hoffert, U., Hornef, M.W., Henriques-Normark, B., Axelsson, L.G., Midtvedt, T., Putsep, K. & Andersson, M. 2008. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 57, 764–771.
24. Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R.N. & Staiano, A. 2009. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 104, 437–443.
25. Mukherjee, S. & Hooper, L.V. 2015. Antimicrobial defense of the intestine. Immunity 42, 28–39.
26. Oh, P.L., Benson, A.K., Peterson, D.A., Patil, P.B., Moriyama, E.N., Roos, S. & Walter, J. 2010. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution. ISME J 4, 377–387.
27. Peran, L., Sierra, S., Comalada, M., Lara-Villoslada, F., Bailon, E., Nieto, A., Concha, A., Olivares, M., Zarzuelo, A., Xaus, J. & Galvez, J. 2007. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97, 96–103.
28. Petersen, C. & Round, J.L. 2014. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16, 1024–1033.
29. Petersson, J., Schreiber, O., Hansson, G.C., Gendler, S.J., Velcich, A., Lundberg, J.O., Roos, S., Holm, L. & Phillipson, M. 2011. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 300, G327–G333.
30. Schreiber, O., Petersson, J., Phillipson, M., Perry, M., Roos, S. & Holm, L. 2009. Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions. Am J Physiol Gastrointest Liver Physiol 296, G534–G542.
31. Schreiber, O., Petersson, J., Walden, T., Ahl, D., Sandler, S., Phillipson, M. & Holm, L. 2013. iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats. PLoS ONE 8, e71843.
32. Sood, A., Midha, V., Makharia, G.K., Ahuja, V., Singal, D., Goswami, P. & Tandon, R.K. 2009. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol, 7, 1202–1209, 1209 e1.
33. Suzuki, T., Yoshinaga, N. & Tanabe, S. 2011. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286, 31263–31271.
34. Tursi, A., Brandimarte, G., Giorgetti, G.M., Forti, G., Modeo, M.E. & Gigliobianco, A. 2004. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit, 10, PI126–PI131.
35. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G.M., Forti, G., Morini, S., Hassan, C., Pistoia, M.A. etal. 2010. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 105, 2218–2227.
36. Ukena, S.N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., Suerbaum, S., Buer, J., Gunzer, F. & Westendorf, A.M. 2007. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2, e1308.
37. Wang, L., Cao, H., Liu, L., Wang, B., Walker, W.A., Acra, S.A. & Yan, F. 2014. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J Biol Chem 289, 20234–20244.
38. Yan, F., Cao, H., Cover, T.L., Washington, M.K., Shi, Y., Liu, L., Chaturvedi, R., Peek, R.M. Jr, Wilson, K.T. & Polk, D.B. 2011. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121, 2242–2253.